Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
The Biofactory Pte. Ltd. has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This single action is assigned to 1 distinct examiner working within 1 distinct art unit, concentrating the firm's current regulatory focus. Because the company is only dealing with 1 distinct examiner, the prosecution strategy is highly streamlined, requiring the practitioner to satisfy the specific requirements of only one individual at the patent office.
PARK, EVELYN GRACE is the busiest examiner for the company, holding the 1 pending office action. This alignment between the total pending actions and the specific examiner indicates a highly focused prosecution path for the current portfolio. The outcome of the company's active matter depends entirely on the technical review performed by PARK, EVELYN GRACE, making it essential to understand this examiner's past history and allowance patterns within the 1 distinct art unit.
In the Medical Devices & Mechanical Engineering sector, a single pending office action represents a targeted effort to secure patent protection. Since there is only 1 distinct examiner involved, there is no opportunity to compare different examination styles within the current portfolio. Practitioners should focus their resources on addressing the specific concerns raised by PARK, EVELYN GRACE to move the 1 pending office action toward a successful conclusion.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PARK, EVELYN GRACE | 1 | 51.6% | +40.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18256919 | BALLOON-ANCHORED FLEXIBLE NEEDLE AND CATHETER FOR BIOPSY | PARK, EVELYN GRACE | 36d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18256919 | BALLOON-ANCHORED FLEXIBLE NEEDLE AND CATHETER FOR BIOPSY | PARK, EVELYN GRACE | 36d |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18256919 | BALLOON-ANCHORED FLEXIBLE NEEDLE AND CATHETER FOR BIOPSY | PARK, EVELYN GRACE | 3791 | §103§112 | Final Rejection | 36d | Pending | Jun 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial